Type 2 diabetes mediating the increased cardiovascular risk in patients with rheumatoid arthritis: a bidirectional mendelian randomisation approach

Back

ESC Professional Premium Access

Type 2 diabetes mediating the increased cardiovascular risk in patients with rheumatoid arthritis: a bidirectional mendelian randomisation approach

Session: Autoimmune and chronic inflammatory disorders and heart disease (2)

Topic: Autoimmune/Chronic Inflammatory Disorders and Heart Disease

Speaker: Associate Professor G. Klappacher (Vienna, AT)

Event: ESC Congress 2024

Congress Presentation

Add to my library

About the speaker

Associate Professor Guenter Klappacher

Medical University of Vienna, Vienna (Austria)

0 follower

8 more presentations in this session

Chronic inflammation is associated with impaired cardiac structure and function in patients with inflammatory arthritis: the ARTCADIA Study

Speaker: Doctor M. Sengelov (Hellerup, DK)

Advanced biologic therapies are associated with fewer adverse cardiovascular events in patients with inflammatory bowel diseases

Speaker: Doctor T. Harb (Baltimore, US)

Vascular thrombosis and relapse-associated factors in Behcet's syndrome: a comprehensive analysis of 136 patients

Speaker: Doctor S. Chadli (Rabat, MA)

The potential effects of methotrexate on cardiovascular outcomes in rheumatoid arthritis patients: a multi-institutional analysis

Speaker: Doctor M. Cervantes (Dallas, US)

Association of inflammation with left ventricular mass index in patients with rheumatoid arthritis

Speaker: Doctor A. Linde (Oslo, NO)

Access the full session

Autoimmune and chronic inflammatory disorders and heart disease (2)

Speakers: Associate Professor G. Klappacher, Doctor M. Sengelov, Doctor T. Harb, Doctor S. Chadli, Doctor M. Cervantes...

Access

About the event

ESC Congress 2024

30 August - 2 September 2024

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources